Cost-Effectiveness: A Key Step in Technology Transfer
暂无分享,去创建一个
[1] Anne C. Haddix,et al. Prevention effectiveness : a guide to decision analysis and economic evaluation , 1996 .
[2] David R. Holtgrave,et al. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. , 2001, AIDS.
[3] C. del Rio,et al. The Economic Burden of HIV in the United States in the Era of Highly Active Antiretroviral Therapy: Evidence of Continuing Racial and Ethnic Differences , 2006, Journal of acquired immune deficiency syndromes.
[4] David R. Holtgrave,et al. A Review of the Cost-Effectiveness of Interventions to Prevent Sexual Transmission of HIV in the United States , 2002, AIDS and Behavior.
[5] David R. Holtgrave,et al. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[6] David R. Holtgrave,et al. Handbook of Economic Evaluation of HIV Prevention Programs , 1998, AIDS Prevention and Mental Health.
[7] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[8] T. Farley,et al. Comparing the Cost-Effectiveness of HIV Prevention Interventions , 2004, Journal of acquired immune deficiency syndromes.
[9] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[10] D R Holtgrave,et al. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[11] Kathryn A. Phillips,et al. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation (second edition) , 2003 .
[12] R Allard. A mathematical model to describe the risk of infection from sharing injection equipment. , 1990, Journal of acquired immune deficiency syndromes.
[13] S. Pinkerton,et al. The Bernoulli-Process Model of HIV Transmission , 1998 .
[14] S. Grosse. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold , 2008, Expert review of pharmacoeconomics & outcomes research.
[15] R Allard. A Family of Mathematical Models to Describe the Risk of Infection by a Sexually Transmitted Agent , 1990, Epidemiology.